HIV-1 highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS)
Imaging
spectrum of abnormal subcutaneous and visceral fat distribution. A 47-year-old man with HALS. a Axial T2-weighted and (b) sagittal T1-weighted images show subcutaneous lipohypertrophy on the posterior neck (arrows). Marked loss of subcutaneous fat including buccal fat pad is shown in the face (arrowheads). c Volume-rendered three-dimensional reformation image shows apparent concave cheeks and periorbital hollowing
HIV-1 highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS)
Siehe auch:
Assoziationen und Differentialdiagnosen zu HIV-1 highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS):